OA11393A - Process for the production of virus in cell cultures. - Google Patents

Process for the production of virus in cell cultures. Download PDF

Info

Publication number
OA11393A
OA11393A OA9900250A OA9900250A OA11393A OA 11393 A OA11393 A OA 11393A OA 9900250 A OA9900250 A OA 9900250A OA 9900250 A OA9900250 A OA 9900250A OA 11393 A OA11393 A OA 11393A
Authority
OA
OAPI
Prior art keywords
virus
cells
process according
cell
culture
Prior art date
Application number
OA9900250A
Other languages
English (en)
Inventor
Freire Marcos Da Silva
Anna Maya Yoshida Yamamura
George Fobes Mann
Ricardo Galler
Original Assignee
Fundacao Oswaldo Cruz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4070797&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=OA11393(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fundacao Oswaldo Cruz filed Critical Fundacao Oswaldo Cruz
Publication of OA11393A publication Critical patent/OA11393A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24151—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
OA9900250A 1998-03-18 1999-11-18 Process for the production of virus in cell cultures. OA11393A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BRPI9804283-1A BR9804283B1 (pt) 1998-03-18 1998-03-18 processo para a produção de flavivìrus em baixa densidade de células em cultura e processo para a produção de flavivìrus recombinante em baixa densidade de células em cultura.

Publications (1)

Publication Number Publication Date
OA11393A true OA11393A (en) 2004-04-08

Family

ID=4070797

Family Applications (1)

Application Number Title Priority Date Filing Date
OA9900250A OA11393A (en) 1998-03-18 1999-11-18 Process for the production of virus in cell cultures.

Country Status (8)

Country Link
EP (1) EP1002054B1 (es)
JP (1) JP2001527422A (es)
BR (1) BR9804283B1 (es)
CA (1) CA2288679A1 (es)
CO (1) CO5050270A1 (es)
DE (1) DE69927769T2 (es)
OA (1) OA11393A (es)
WO (1) WO1999047645A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201503854UA (en) 2012-11-22 2015-06-29 Asahi Kasei Medical Co Ltd Method for producing parvovirus having high infectivity titer
GB201310031D0 (en) 2013-06-05 2013-07-17 Pirbright Inst The Cell
WO2022119560A1 (en) * 2020-12-01 2022-06-09 National Health Research Institutes Cell strain having increased virus production ability and production method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT393277B (de) * 1990-01-04 1991-09-25 Immuno Ag Verfahren zur herstellung von fruehsommer- meningoenzephalitis-virus (fsme-virus)-antigen
ES2026827A6 (es) * 1991-03-26 1992-05-01 Ercros Sa Procedimiento para la produccion de una vacuna subunidad contra el parvovirus porcino.
FR2689520B1 (fr) * 1992-04-03 1996-07-19 Bio Merieux Procede et milieu de culture pour l'obtention de cellules infectees par un virus associe a la sclerose en plaques.

Also Published As

Publication number Publication date
EP1002054B1 (en) 2005-10-19
EP1002054A1 (en) 2000-05-24
WO1999047645A1 (en) 1999-09-23
CA2288679A1 (en) 1999-09-23
CO5050270A1 (es) 2001-06-27
BR9804283B1 (pt) 2010-11-30
BR9804283A (pt) 2000-04-04
JP2001527422A (ja) 2001-12-25
DE69927769D1 (de) 2006-03-02
DE69927769T2 (de) 2006-07-20

Similar Documents

Publication Publication Date Title
CN101454022B (zh) 假性感染性黄病毒及其用途
JP4993301B2 (ja) 日本脳炎ウイルスおよび西ナイルウイルスに対するワクチン
JP3681358B2 (ja) キメラおよび／または増殖制限されたフラビウイルス
JP4161017B2 (ja) ベロ細胞に適応させた弱毒化日本脳炎ウィルスおよび日本脳炎ワクチン
CHEN et al. Persistence of Japanese encephalitis virus is associated with abnormal expression of the nonstructural protein NS1 in host cells
RU2465326C2 (ru) Рекомбинантные флавивирусные вакцины
Romanova et al. Microevolution of tick-borne encephalitis virus in course of host alternation
US20130095136A1 (en) Tetravalent Dengue Vaccines
KR102626270B1 (ko) 백신 내의 뎅기 바이러스 키메라 구조체를 위한 조성물 및 방법
Pletnev Infectious cDNA clone of attenuated Langat tick-borne flavivirus (strain E5) and a 3′ deletion mutant constructed from it exhibit decreased neuroinvasiveness in immunodeficient mice
JP2004520406A (ja) 弱毒生ワクチン
US20030180329A1 (en) Viral vaccine production method
EP1002054B1 (en) Process for the production of virus in cell cultures
TWI835787B (zh) 在ｖｅｒｏ細胞上生長之減毒活黃熱病病毒株及包含其之疫苗組成物
KR100647892B1 (ko) 세포배양을 통한 바이러스의 생산 방법
JP6026419B2 (ja) 遺伝子型３ａのＣ型肝炎ウイルスゲノム由来の核酸を含む核酸構築物
AU2009211379A1 (en) Flaviviridae mutants comprising a deletion in the capsid protein for use as vaccines
RU2795800C1 (ru) Иммунобиологическое средство для профилактики заболеваний, вызванных вирусом клещевого энцефалита на основе рекомбинантного вируса рода Flavivirus
US6613556B1 (en) Adaptation of virus to vertebrate cells
ITMI991408A1 (it) Processo per la produzione di virus in colture cellulari